FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

372601001: Levocarnitine (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
2536513012 Levocarnitine en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3672166010 Levocarnitine (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3744781016 L-carnitine en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT core
2805591000005115 L-Carnitin da Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) Danish module (core metadata concept)


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Levocarnitine Is a Vitamin B and/or vitamin B derivative (substance) true Inferred relationship Some
Levocarnitine Is a Antilipemic agent (substance) true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Levocarnitine Is a False Levocarnitine Inferred relationship Some
L-Carnitine adverse reaction Causative agent True Levocarnitine Inferred relationship Some 1
Allergy to levocarnitine (finding) Causative agent False Levocarnitine Inferred relationship Some
Carnitine deficiency products The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Levocarnitine Inferred relationship Some
Product containing levocarnitine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Levocarnitine Inferred relationship Some 1
L-carnitin 30 % pædiatrisk opløsning The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Levocarnitine Inferred relationship Some
L-carnitin 1 g/10 ml enkeltdosis, oral opløsning The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Levocarnitine Inferred relationship Some
L-carnitin 1 g injektionsvæske, opløsning, ampul a 5 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Levocarnitine Inferred relationship Some
Product containing precisely levocarnitine 100 milligram/1 milliliter conventional release oral solution (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Levocarnitine Inferred relationship Some
Levocarnitine 330 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Levocarnitine Inferred relationship Some
Levocarnitin 200 mg/ml injektionsvæske, opløsning, ampul The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Levocarnitine Inferred relationship Some
Levocarnitin 200 mg/ml injektionsvæske, opløsning, ampul a 5 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Levocarnitine Inferred relationship Some
Product containing levocarnitine in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Levocarnitine Inferred relationship Some 1
levocarnitin 1 g/10 ml sukkerfri oral opløsning The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Levocarnitine Inferred relationship Some
Product containing levocarnitine in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Levocarnitine Inferred relationship Some 1
Allergy to levocarnitine (finding) Causative agent True Levocarnitine Inferred relationship Some 1
Levocarnitine 330 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Levocarnitine Inferred relationship Some 1
Levocarnitine 330 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Levocarnitine Inferred relationship Some 1
Levocarnitine 330 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Levocarnitine Inferred relationship Some 1
Levocarnitine only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Levocarnitine Inferred relationship Some 1
Product containing only levocarnitine in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Levocarnitine Inferred relationship Some 1
Levocarnitine only product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Levocarnitine Inferred relationship Some 1
Product containing precisely levocarnitine 100 milligram/1 milliliter conventional release oral solution (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Levocarnitine Inferred relationship Some 1
Product containing precisely levocarnitine 100 milligram/1 milliliter conventional release oral solution (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Levocarnitine Inferred relationship Some 1
Product containing precisely levocarnitine 300 milligram/1 milliliter conventional release oral solution (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Levocarnitine Inferred relationship Some 1
Product containing precisely levocarnitine 300 milligram/1 milliliter conventional release oral solution (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Levocarnitine Inferred relationship Some 1
Levocarnitine 200 mg/mL solution for injection The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Levocarnitine Inferred relationship Some 1
Levocarnitine 200 mg/mL solution for injection This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Levocarnitine Inferred relationship Some 1
Product containing precisely levocarnitine 500 milligram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Levocarnitine Inferred relationship Some 1
Product containing precisely levocarnitine 500 milligram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Levocarnitine Inferred relationship Some 1

This concept is not in any reference sets

Back to Start